VILINBIO

Vilin Bio Med Share Price

₹26.20 +0.45 (1.75%)

10 Jul, 2025 22:17

SIP TrendupStart SIP in VILINBIO

Start SIP

Performance

  • Low
  • ₹26
  • High
  • ₹26
  • 52 Week Low
  • ₹15
  • 52 Week High
  • ₹33
  • Open Price₹0
  • Previous Close₹26
  • Volume20,000

Investment Returns

  • Over 1 Month -2.42%
  • Over 3 Month -8.23%
  • Over 6 Month + 13.42%
  • Over 1 Year + 37.89%
SIP Lightning

Smart Investing Starts Here Start SIP with Vilin Bio Med for Steady Growth!

Invest Now

Vilin Bio Med Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 163.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 37
  • P/B Ratio
  • 1.6
  • Average True Range
  • 0.58
  • EPS
  • 0.16
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.07
  • RSI
  • 42.51
  • MFI
  • 12.07

Vilin Bio Med Financials

Vilin Bio Med Technicals

EMA & SMA

Current Price
₹26.20
+ 0.45 (1.75%)
pointer
  • stock-down_img
  • Bearish Moving Average 8
  • stock-up_img
  • Bullish Moving Average 8
  • 20 Day
  • ₹26.72
  • 50 Day
  • ₹26.12
  • 100 Day
  • ₹24.65
  • 200 Day
  • ₹23.34

Resistance and Support

25.75 Pivot Speed
  • R3 25.75
  • R2 25.75
  • R1 25.75
  • S1 25.75
  • S2 25.75
  • S3 25.75

What's your outlook on Vilin Bio Med?

You can only vote once!

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Vilin Bio Med Ltd has an operating revenue of Rs. 38.26 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 70 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vilin Bio Med Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-17 Audited Results
2025-01-10 To consider Fund Raising & Others To consider other business matters.
2024-10-30 Quarterly Results
2024-05-29 Audited Results
2023-11-10 Quarterly Results

Vilin Bio Med F&O

Vilin Bio Med Shareholding Pattern

63.89%
34.18%
1.93%

About Vilin Bio Med

  • NSE Symbol
  • VILINBIO
  • BSE Symbol
  • Managing Director
  • Mr. Viswa Prasad Sadhanala
  • ISIN
  • INE0L4V01013

Similar Stocks to Vilin Bio Med

Vilin Bio Med FAQs

Vilin Bio Med share price is ₹26 As on 10 July, 2025 | 22:03

The Market Cap of Vilin Bio Med is ₹36.5 Cr As on 10 July, 2025 | 22:03

The P/E ratio of Vilin Bio Med is 163.5 As on 10 July, 2025 | 22:03

The PB ratio of Vilin Bio Med is 1.6 As on 10 July, 2025 | 22:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23